Seeing Is Believing
Healthcare - Sector
KYMR is currently covered by 18 analysts with an average price target of $120.09. This is a potential upside of $27.5 (4.46%) from yesterday's end of day stock price of $114.96.
Kymera Therapeutics's activity chart (see below) currently has 154 price targets and 162 ratings on display. The stock rating distribution of KYMR is 97.5% BUY and 2.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 91.13% with an average time for these price targets to be met of 317.79 days.
Highest price target for KYMR is $180, Lowest price target is $67, average price target is $120.09.
Most recent stock forecast was given by ANDY CHEN from WOLFE. First documented stock forecast 15-Sep-2020.
Currently out of the existing stock ratings of KYMR, 39 are a BUY (97.5%), 1 are a HOLD (2.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Sep-2026
$180
$65.04 (56.58%)
Buy Since 26-Jun-2025
$151
$36.04 (31.35%)
$116
17 days ago
(27-Aug-2026)
11/12 (91.67%)
$30.77 (25.59%)
271
Buy Since 21-May-2021
$139
$24.04 (20.91%)
$70
1 months 7 days ago
(06-Aug-2026)
5/6 (83.33%)
$32.59 (30.63%)
549
Buy Since 16-Sep-2025
$115
$0.04 (0.03%)
$103
2 months ago
(13-Jul-2026)
3/3 (100%)
$4.6 (4.17%)
93
Buy Since 30-Jul-2025
$155
$40.04 (34.83%)
2 months 15 days ago
(29-Jun-2026)
8/9 (88.89%)
$45.68 (41.79%)
273
What is KYMR (Kymera Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on KYMR (Kymera Therapeutics)?
Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?
Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?
Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?